ストックスクリーナーアプリを入手
38.87
0.57%
0.22
アフターアワーズ：
38.87
前日終値:
$38.65
開ける：
$38.5
24時間の取引高:
385.64K
Relative Volume:
0.35
時価総額：
$3.00B
収益：
$13.17M
当期純損益:
$-199.06M
株価収益率:
-14.19
EPS:
-2.74
ネットキャッシュフロー:
$-156.53M
1週間 パフォーマンス:
+3.27%
1か月 パフォーマンス:
+28.28%
6か月 パフォーマンス:
+1.46%
1年 パフォーマンス:
-5.03%
1日の値動き範囲:
$38.19
$39.15
1週間の範囲:
$37.05
$39.58
52週間の値動き範囲:
$26.74
$46.00
Xenon Pharmaceuticals Inc Stock (XENE) Company Profile
名前
Xenon Pharmaceuticals Inc
セクター
電話
(604) 484-3300
住所
200 - 3650 GILMORE WAY, BURNABY
XENE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XENE
Xenon Pharmaceuticals Inc
|
38.87 | 2.94B | 13.17M | -199.06M | -156.53M | -2.74 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.50 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-07 | 開始されました | Chardan Capital Markets | Buy |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-10-01 | 開始されました | H.C. Wainwright | Buy |
| 2024-01-04 | 開始されました | Citigroup | Buy |
| 2023-12-08 | 開始されました | Robert W. Baird | Outperform |
| 2023-10-24 | 再開されました | Cantor Fitzgerald | Overweight |
| 2023-04-25 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-12-14 | 開始されました | Goldman | Buy |
| 2022-12-12 | 開始されました | Cowen | Outperform |
| 2022-11-28 | 開始されました | Wells Fargo | Overweight |
| 2022-10-19 | 開始されました | Raymond James | Outperform |
| 2022-08-29 | 開始されました | BofA Securities | Buy |
| 2022-07-21 | 開始されました | JP Morgan | Overweight |
| 2021-10-28 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-10-02 | 開始されました | SVB Leerink | Outperform |
| 2020-07-21 | 開始されました | Needham | Buy |
| 2020-06-01 | 再開されました | Jefferies | Buy |
| 2020-03-25 | 開始されました | Wedbush | Outperform |
| 2020-01-08 | 開始されました | William Blair | Outperform |
| 2019-09-20 | 開始されました | Guggenheim | Buy |
| 2018-08-08 | 繰り返されました | Stifel | Buy |
| 2017-03-13 | 開始されました | Jefferies | Buy |
| 2016-10-21 | 開始されました | Stifel | Buy |
| 2016-09-26 | 開始されました | Guggenheim | Buy |
| 2016-04-14 | 繰り返されました | Jefferies | Buy |
| 2015-10-30 | 再開されました | Jefferies | Buy |
| 2014-12-02 | 開始されました | Canaccord Genuity | Buy |
すべてを表示
Xenon Pharmaceuticals Inc (XENE) 最新ニュース
Xenon Pharmaceuticals Inc. Builds Base for Possible Rebound getLinesFromResByArray error: size == 0 - 더경남뉴스
Are Bears Losing Grip on Xenon Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Understanding Xenon Pharmaceuticals Inc.’s price movementSwing Trade & Accurate Intraday Trading Signals - Newser
Xenon Pharmaceuticals Inc. stock volume spike explainedEarnings Beat & Free Low Drawdown Momentum Trade Ideas - Newser
How to integrate Xenon Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 Earnings & Reliable Volume Spike Alerts - Newser
Advanced analytics toolkit walkthrough for Xenon Pharmaceuticals Inc.Portfolio Update Summary & Target Return Focused Stock Picks - Newser
Analyzing Xenon Pharmaceuticals Inc. with risk reward ratio chartsTrade Ideas & Stepwise Trade Signal Implementation - Newser
Should you wait for a breakout in Xenon Pharmaceuticals Inc.Watch List & Weekly Breakout Stock Alerts - Newser
Xenon Pharmaceuticals Inc. Recovery Likely Here’s What Data Shows getLinesFromResByArray error: size == 0 - newsyoung.net
Published on: 2025-08-26 14:28:29 - Newser
Using fundamentals and technicals on Xenon Pharmaceuticals Inc.Exit Point & Momentum Based Trading Ideas - Newser
Xenon Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayQuarterly Market Review & Weekly Top Gainers Trade List - Newser
Key resistance and support levels for Xenon Pharmaceuticals Inc.2025 Price Action Summary & Fast Entry Momentum Alerts - Newser
Focal Epilepsy Market: Epidemiology, Pipeline, Companies, DelveInsight | Biocodex, Biohaven Therapeutics Ltd., Xenon Pharmaceuticals Inc., UCB Pharma, SK Life Science Inc., Jazz Pharmaceuticals, Verte - Barchart.com
Heatmap Data Shows High Activity in Xenon Pharmaceuticals Inc. Sector2025 Geopolitical Influence & Free Low Drawdown Momentum Trade Ideas - 더경남뉴스
Resistance Break Could Fuel Xenon Pharmaceuticals Inc. RallyJuly 2025 Pullbacks & Fast Entry Momentum Alerts - beatles.ru
Published on: 2025-08-25 08:56:05 - Newser
Evaluating Xenon Pharmaceuticals Inc. with trendline analysisMarket Sentiment Report & High Accuracy Swing Entry Alerts - Newser
Using AI based signals to follow Xenon Pharmaceuticals Inc.Quarterly Investment Review & Daily Growth Stock Tips - Newser
Signal strength of Xenon Pharmaceuticals Inc. stock in tech scannersJobs Report & Smart Swing Trading Alerts - Newser
Institutional scanner results for Xenon Pharmaceuticals Inc.Market Weekly Review & Free High Accuracy Swing Entry Alerts - Newser
Xenon Pharmaceuticals Inc. Facing Inflection Point in Trend AnalysisPortfolio Return Report & Fast Moving Stock Watchlists - beatles.ru
Xenon Pharmaceuticals' (XENE) Shift in Risk Profile and Market Reassessment: Navigating Clinical Setbacks in a High-Stakes Biotech Landscape - AInvest
Did Higher-Than-Expected Losses Just Shift Xenon Pharmaceuticals' (XENE) Investment Narrative? - Yahoo Finance
Is Xenon Pharmaceuticals Inc. stock reversal real or fakeWall Street Watch & Long-Term Capital Growth Ideas - Newser
What is Xenon Pharmaceuticals Inc.’s market position2025 Key Lessons & High Conviction Trade Alerts - theviewers.co.kr
Earnings call transcript: Xenon Pharmaceuticals Q2 2025 earnings beat By Investing.com - Investing.com Nigeria
Published on: 2025-08-21 22:12:50 - beatles.ru
Earnings call transcript: Xenon Pharmaceuticals Q2 2025 earnings beat - Investing.com
Is Xenon Pharmaceuticals Inc. a candidate for recovery playEarnings Growth Summary & Weekly Hot Stock Watchlists - Newser
Xenon Pharmaceuticals Inc. Rebounds From Oversold Zone — Now WhatWeekly Market Report & Free Long-Term Investment Growth Plans - newsyoung.net
Quantitative breakdown of Xenon Pharmaceuticals Inc. recent moveQuarterly Earnings Summary & Real-Time Volume Analysis - Newser
Published on: 2025-08-20 13:12:52 - beatles.ru
Is Xenon Pharmaceuticals Inc. still worth holding after the dipLayoff News & Accurate Buy Signal Notifications - Newser
Xenon Pharmaceuticals Inc. stock trendline breakdownGold Moves & Breakout Confirmation Trade Signals - Newser
Can Xenon Pharmaceuticals Inc. sustain its profitability2025 Market WrapUp & Weekly Chart Analysis and Trade Guides - thegnnews.com
Is a relief rally coming for Xenon Pharmaceuticals Inc. holdersJuly 2025 Momentum & Weekly Stock Performance Updates - Newser
How to use Fibonacci retracement on Xenon Pharmaceuticals Inc.2025 Technical Patterns & Growth Focused Stock Pick Reports - Newser
Can Traders Expect Breakout From Xenon Pharmaceuticals Inc. This WeekJuly 2025 Price Swings & Technical Buy Zone Confirmations - kangso.co.kr
Is Xenon Pharmaceuticals Inc. Stock a Good Fit for Conservative InvestorsTrade Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Will Xenon Pharmaceuticals Inc. continue its uptrend2025 Volatility Report & Weekly High Momentum Picks - Newser
Are Xenon Pharmaceuticals’ (XENE) Widening Losses Signaling a Pivotal Shift in R&D Strategy? - simplywall.st
Research Analysts Issue Forecasts for XENE FY2025 Earnings - Defense World
HC Wainwright Issues Negative Outlook for XENE Earnings - Defense World
Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus - MSN
Will a bounce in Xenon Pharmaceuticals Inc. offer an exitJuly 2025 Movers & Community Verified Swing Trade Signals - Newser
Identifying reversal signals in Xenon Pharmaceuticals Inc.Weekly Risk Summary & Capital Efficient Trading Techniques - Newser
Xenon targets NDA filing for azetukalner within 6 months of phase III readout while advancing late-stage neuropsychiatric programs - MSN
What is William Blair’s Forecast for XENE FY2027 Earnings? - Defense World
Xenon Pharmaceuticals Reports Q2 2025 Progress and Outlook - MSN
Why Xenon Pharmaceuticals’ Stock is Climbing - TipRanks
Xenon Pharmaceuticals Inc (XENE) 財務データ
収益
当期純利益
現金流量
EPS
Xenon Pharmaceuticals Inc (XENE) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| GANNON STEVEN | Director |
May 14 '25 |
Option Exercise |
12.57 |
5,144 |
64,660 |
7,144 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 24 '25 |
Option Exercise |
17.76 |
22,468 |
399,032 |
53,770 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 27 '25 |
Option Exercise |
17.76 |
16,315 |
289,754 |
46,468 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 23 '25 |
Option Exercise |
17.76 |
16,217 |
288,014 |
47,519 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 24 '25 |
Sale |
40.20 |
22,468 |
903,214 |
31,302 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 27 '25 |
Sale |
40.50 |
16,315 |
660,806 |
31,302 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 23 '25 |
Sale |
40.08 |
16,217 |
649,977 |
31,302 |
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):